Literature DB >> 9549028

The effects of depression and abnormal illness behaviour on outcome following rehabilitation from stroke.

M S Clark1, D S Smith.   

Abstract

OBJECTIVE: To examine the relative effects of depression and abnormal illness behaviour (AIB) on long-term rehabilitation outcome following stroke.
DESIGN: A longitudinal design, with assessments on admission to and discharge from rehabilitation, and six and twelve months after discharge.
SETTING: The study was undertaken in the rehabilitation unit at Repatriation General Hospital, in Adelaide, South Australia.
SUBJECTS: Ninety-four twelve-month stroke survivors who had undergone an inpatient rehabilitation programme. MAIN OUTCOME MEASURES: AIB was assessed using the Illness Behaviour Questionnaire, and depression with the Zung Self-Rating Depression Scale. The General Health Questionnaire and a visual analogue mood scale were also used. Functional outcome was assessed with the competence and performance assessments of the Australian ADL Index, and lifestyle activities with the Frenchay Activities Index.
RESULTS: Multivariate analysis of outcome controlled for age and stroke severity. AIB was a better predictor of functional competence and performance than either age or stroke severity, at rehabilitation discharge and both six and twelve months later. Depression was not related to functional competence and performance at any assessment, but was strongly predictive of an inactive lifestyle at both six and twelve months. By contrast, lifestyle activities were not related to AIB.
CONCLUSIONS: Depression and AIB appear to have quite distinct effects on outcome. AIB emerged as a key determinant of long-term functional disability, while depression was associated with poorer social functioning. The early recognition and treatment of AIB and depression is important for the ultimate social and functional outcomes of stroke rehabilitation patients.

Entities:  

Mesh:

Year:  1998        PMID: 9549028     DOI: 10.1191/026921598669567216

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  8 in total

1.  Late-Life Depressive and Anxiety Symptoms Following Rehabilitation Services in Medicare Beneficiaries.

Authors:  Adam Simning; Julie Kittel; Yeates Conwell
Journal:  Am J Geriatr Psychiatry       Date:  2018-12-13       Impact factor: 4.105

2.  Relation of depressive symptoms to outcome of CI movement therapy after stroke.

Authors:  Michelle M Haddad; Gitendra Uswatte; Edward Taub; Ameen Barghi; Victor W Mark
Journal:  Rehabil Psychol       Date:  2017-11

Review 3.  Post-stroke depression: an update.

Authors:  D W Gawronski; M J Reding
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

4.  Poststroke Neuropsychiatric Illness: An Integrated Approach to Diagnosis and Management.

Authors:  James A. Bourgeois; Donald M. Hilty; Celia H. Chang; Mark A. Wineinger; Mark E. Servis
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

5.  Living well with stroke: design and methods for a randomized controlled trial of a psychosocial behavioral intervention for poststroke depression.

Authors:  Pamela H Mitchell; Linda Teri; Richard Veith; Ann Buzaitis; David Tirschwell; Kyra Becker; Michael Fruin; Ruth Kohen; Kevin C Cain
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 May-Jun       Impact factor: 2.136

6.  Assessing abnormal illness behavior in post-stroke patients: a preliminary report.

Authors:  Geetha Desai; Avinash Waghmare; Santosh K Chaturvedi
Journal:  Indian J Psychol Med       Date:  2014-10

7.  A Role for YouTube in Telerehabilitation.

Authors:  M Hunter Manasco; Nicholas Barone; Amanda Brown
Journal:  Int J Telerehabil       Date:  2010-10-27

8.  Can force feedback and science learning enhance the effectiveness of neuro-rehabilitation? An experimental study on using a low-cost 3D joystick and a virtual visit to a zoo.

Authors:  Paolo Cappa; Andrea Clerico; Oded Nov; Maurizio Porfiri
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.